Literature DB >> 20843265

Comparison of XTT and Alamar blue assays in the assessment of the viability of various human cancer cell lines by AT-101 (-/- gossypol).

Selim Uzunoglu1, Burcak Karaca, Harika Atmaca, Asli Kisim, Canfeza Sezgin, Bulent Karabulut, Ruchan Uslu.   

Abstract

This study compared the two different commercially available in vitro viability assays: XTT and Alamar blue (AB), to detect anti-proliferative effects of AT-101, a cotton plant extract, on six different human carcinoma cell lines including: prostate (PC-3 and DU-145), breast (MCF-7 and MDA-MB-231), and ovary (OVCAR-3 and MDAH 2774) in a time- and dose-dependent manner. Cells were exposed to AT-101 in the concentration range of 2.5-40 µM for 24, 48, and 72 h. The AB assay was slightly more sensitive than the XTT assay in the evaluation of AT-101 at 24 h, suggesting that the AB assay might be used for detecting early changes in cell viability as compared to the XTT assay. Moreover, the AB assay showed less intra-assay variability as compared to the XTT. The non-toxic, non-radioactive AB metabolism assay allows rapid assessment of large numbers of samples, with simple equipment and at reduced cost for continuous monitoring of cancer cell viability, and, thus, should be accepted as a suitable alternative viability method.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20843265     DOI: 10.3109/15376516.2010.508080

Source DB:  PubMed          Journal:  Toxicol Mech Methods        ISSN: 1537-6516            Impact factor:   2.987


  9 in total

1.  Protection of Nrf2 against arsenite-induced oxidative damage is regulated by the cyclic guanosine monophosphate-protein kinase G signaling pathway.

Authors:  Chengzhi Chen; Xuejun Jiang; Shiyan Gu; Yanhao Lai; Yuan Liu; Zunzhen Zhang
Journal:  Environ Toxicol       Date:  2016-10-24       Impact factor: 4.119

2.  Pivotal role of mitophagy in response of acute myelogenous leukemia to a ceramide-tamoxifen-containing drug regimen.

Authors:  Samy A F Morad; Matthew R MacDougall; Noha Abdelmageed; Li-Pin Kao; David J Feith; Su-Fern Tan; Mark Kester; Thomas P Loughran; Hong-Gang Wang; Myles C Cabot
Journal:  Exp Cell Res       Date:  2019-05-18       Impact factor: 3.905

3.  Quantitative Validation of the Presto Blue Metabolic Assay for Online Monitoring of Cell Proliferation in a 3D Perfusion Bioreactor System.

Authors:  Maarten Sonnaert; Ioannis Papantoniou; Frank P Luyten; Jan Ir Schrooten
Journal:  Tissue Eng Part C Methods       Date:  2015-03-31       Impact factor: 3.056

4.  The Plasmodium circumsporozoite protein, a novel NF-κB inhibitor, suppresses the growth of SW480.

Authors:  Yan Ding; Xiaobing Huang; Taiping Liu; Yong Fu; Zhangping Tan; Hong Zheng; Taoli Zhou; Jigang Dai; Wenyue Xu
Journal:  Pathol Oncol Res       Date:  2012-06-08       Impact factor: 3.201

5.  Real-time luminescence enables continuous drug-response analysis in adherent and suspension cell lines.

Authors:  Clayton M Wandishin; Charles John Robbins; Darren R Tyson; Leonard A Harris; Vito Quaranta
Journal:  Cancer Biol Ther       Date:  2022-12-31       Impact factor: 4.875

6.  Identification of novel compounds inhibiting chikungunya virus-induced cell death by high throughput screening of a kinase inhibitor library.

Authors:  Deu John M Cruz; Rafaela M Bonotto; Rafael G B Gomes; Camila T da Silva; Juliana B Taniguchi; Joo Hwan No; Benoit Lombardot; Olivier Schwartz; Michael A E Hansen; Lucio H Freitas-Junior
Journal:  PLoS Negl Trop Dis       Date:  2013-10-31

7.  Development and preclinical evaluation of microneedle-assisted resveratrol loaded nanostructured lipid carriers for localized delivery to breast cancer therapy.

Authors:  Shivaprasad Gadag; Reema Narayan; Archana S Nayak; Diana Catalina Ardila; Shilpa Sant; Yogendra Nayak; Sanjay Garg; Usha Y Nayak
Journal:  Int J Pharm       Date:  2021-07-10       Impact factor: 6.510

8.  Enzymatic surface erosion of high tensile strength polycarbonates based on natural phenols.

Authors:  Sven D Sommerfeld; Zheng Zhang; Marius C Costache; Sebastián L Vega; Joachim Kohn
Journal:  Biomacromolecules       Date:  2014-02-03       Impact factor: 6.988

9.  The Comparison of MTT and CVS Assays for the Assessment of Anticancer Agent Interactions.

Authors:  Lidia Śliwka; Katarzyna Wiktorska; Piotr Suchocki; Małgorzata Milczarek; Szymon Mielczarek; Katarzyna Lubelska; Tomasz Cierpiał; Piotr Łyżwa; Piotr Kiełbasiński; Anna Jaromin; Anna Flis; Zdzisław Chilmonczyk
Journal:  PLoS One       Date:  2016-05-19       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.